Response to Comment on: Jones et al. Testosterone Replacement in Hypogonadal Men With Type 2 Diabetes and/or Metabolic Syndrome (the TIMES2 Study). Diabetes Care 2011;34:828–837

Por Jones, T. Hugh, Howell, Julian D., Channer, Kevin S.
Publicado em 2011

Use of transdermal and intravenous granisetron and the ability of the Hesketh score to assess nausea and vomiting induced by multiday chemotherapy

Por Boccia, Ralph V, Clark, Gemma, Howell, Julian D
Publicado em 2012

Efficacy and tolerability of transdermal granisetron for the control of chemotherapy-induced nausea and vomiting associated with moderately and highly emetogenic multi-day chemothe...

Por Boccia, Ralph V., Gordan, Lucio N., Clark, Gemma, Howell, Julian D., Grunberg, Steven M.
Publicado em 2010

Testosterone Replacement in Hypogonadal Men With Type 2 Diabetes and/or Metabolic Syndrome (the TIMES2 Study)

Por Jones, T. Hugh, Arver, Stefan, Behre, Hermann M., Buvat, Jacques, Meuleman, Eric, Moncada, Ignacio, Morales, Antonio Martin, Volterrani, Maurizio, Yellowlees, Ann, Howell, Julian D., Channer, Kevin S.
Publicado em 2011